Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. S-1/A Offering Registration Statement
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13D Stake Beneficial Ownership Report
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Director acquired 166,667 shares (grant or award)
  14. 4 Grant or award Director acquired 834,334 shares (grant or award)
  15. 4 Grant or award Director acquired 1,500,000 shares (grant or award)
  16. SC 13D/A Stake Beneficial Ownership Report
  17. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  18. 8-K Event Results of operations · Regulation FD disclosure
  19. UPLOAD Other SEC-generated Letter
  20. S-1/A Offering Registration Statement

Page 12 of 33 · 659 filings